Latest News Posts
DEA Moves to Classify Kratom Extract as Schedule I Opioid
The U.S. Drug Enforcement Administration has moved to classify synthetic 7-OH kratom extract as a Schedule I opioid, filing formal notice to temporarily place 7-hydroxymitragynine, known as 7-OH, and...
Written By: Quentin Blount
July 17, 2026
Fentanyl Deaths Fell 22% Nationwide, CDC Data Shows
Written By: Terri Beth Miller
July 16, 2026
Study Links Cosmetic Procedures to Addictive Patterns
Written By: Nikki Wisher
July 16, 2026
Federal Plan Targets Mental Health Treatment Overprescribing
Written By: Courtney Myers
July 15, 2026
AI Speeds Up Drug Testing for Addiction Treatment
Written By: Peter Lee
July 15, 2026
All News Posts
AMA Notes Possible Cannabis Benefits for Seniors, With Caveats
The American Medical Association has acknowledged that cannabis may offer some...
Continue Reading
Patients Trust Addiction Treatment Staff With Lived Experience
People walking into addiction treatment for the first time often carry shame,...
Continue Reading
Federal Workplace Drug Testing Rules Affect Addiction Treatment
Workplace drug policy is entering one of its biggest shifts in years, and the...
Continue Reading
Low Confidence and Distorted Beliefs Limit Recovery, Study Finds
For anyone weighing addiction treatment, a new study offers a practical...
Continue Reading
Majority of 8th Graders Underestimate Fentanyl Risk, Research Finds
Many U.S. adolescents do not recognize how dangerous fentanyl is, and that...
Continue Reading


































































































